{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,1,12]],"date-time":"2026-01-12T23:09:01Z","timestamp":1768259341006,"version":"3.49.0"},"reference-count":40,"publisher":"Oxford University Press (OUP)","issue":"8","license":[{"start":{"date-parts":[[2020,4,1]],"date-time":"2020-04-01T00:00:00Z","timestamp":1585699200000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/academic.oup.com\/journals\/pages\/open_access\/funder_policies\/chorus\/standard_publication_model"}],"funder":[{"name":"French Ministry of Higher Education, Research and Innovation"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2020,4,1]]},"abstract":"<jats:title>ABSTRACT<\/jats:title>\n               <jats:p>The increasing spread of antibiotic resistant bacteria is a major human health concern. The challenging development of new effective antibiotics has led to focus on seeking synergistic antibiotic combinations. Vancomycin (VAN) is a glycopeptide antibiotic used to treat Staphylococcus aureus and enterococci infections. It is targeting D-Alanyl-D-Alanine dimers during peptidoglycan biosynthesis. D-cycloserine (DCS) is a D-Alanine analogue that targets peptidoglycan biosynthesis by inhibiting D-Alanine:D-Alanine ligase (Ddl). The VAN-DCS combination was found to be synergistic in VAN resistant S. aureus strains lacking van genes cluster. We hypothesize that this combination leads to opposite effects in S. aureus and enterococci strains harboring van genes cluster where VAN resistance is conferred by the synthesis of modified peptidoglycan precursors ending in D-Alanyl-D-Lactate. The calculated Fractional Inhibitory Concentration of VAN-DCS combination in a van- vancomycin-intermediate, VanA type, and VanB type strains were 0.5, 5 and 3, respectively. As a result, VAN-DCS combination leads to synergism in van-lacking strains, and to antagonism in strains harboring van genes cluster. The VAN-DCS antagonism is due to a mechanism that we named van-mediated Ddl inhibition bypass. Our results show that antibiotic combinations can lead to opposite effects depending on the genetic backgrounds.<\/jats:p>","DOI":"10.1093\/femsle\/fnaa062","type":"journal-article","created":{"date-parts":[[2020,4,8]],"date-time":"2020-04-08T19:13:33Z","timestamp":1586373213000},"source":"Crossref","is-referenced-by-count":6,"title":["Opposite effect of vancomycin and D-Cycloserine combination in both vancomycin resistant <i>Staphylococcus aureus<\/i> and enterococci"],"prefix":"10.1093","volume":"367","author":[{"ORCID":"https:\/\/orcid.org\/0000-0003-0001-7577","authenticated-orcid":false,"given":"Abdelhakim","family":"Boudrioua","sequence":"first","affiliation":[{"name":"Normandie Univ, UNICAEN, U2RM, 14000, Caen, France"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yanyan","family":"Li","sequence":"additional","affiliation":[{"name":"Laboratory Molecules of Communication and Adaptation of Microorganisms (MCAM, UMR 7245 CNRS-MNHN), National Museum of Natural History (MNHN), CNRS, CP 54, 57 rue Cuvier 75005, Paris, France"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Axel","family":"Hartke","sequence":"additional","affiliation":[{"name":"Normandie Univ, UNICAEN, U2RM, 14000, Caen, France"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-8294-3218","authenticated-orcid":false,"given":"Caroline","family":"Giraud","sequence":"additional","affiliation":[{"name":"Normandie Univ, UNICAEN, U2RM, 14000, Caen, France"}],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"286","published-online":{"date-parts":[[2020,4,11]]},"reference":[{"key":"2022032112124092000_bib1","doi-asserted-by":"crossref","first-page":"266","DOI":"10.1038\/nrmicro2761","article-title":"The rise of the enterococcus: beyond vancomycin resistance","volume":"10","author":"Arias","year":"2012","journal-title":"Nat Rev Microbiol"},{"key":"2022032112124092000_bib2","doi-asserted-by":"crossref","first-page":"117","DOI":"10.1128\/jb.175.1.117-127.1993","article-title":"Characterization of Tn1546, a Tn3-related transposon conferring glycopeptide resistance by synthesis of depsipeptide peptidoglycan precursors in Enterococcus faecium BM4147","volume":"175","author":"Arthur","year":"1993","journal-title":"J Bacteriol"},{"key":"2022032112124092000_bib3","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1038\/s41467-017-02118-7","article-title":"Inhibition of D-Ala:D-Ala ligase through a phosphorylated form of the antibiotic D-cycloserine","volume":"8","author":"Batson","year":"2017","journal-title":"Nat Commun"},{"key":"2022032112124092000_bib4","doi-asserted-by":"crossref","first-page":"3190","DOI":"10.1093\/jac\/dku297","article-title":"Generation of a vancomycin-intermediate Staphylococcus aureus (VISA) strain by two amino acid exchanges in VraS","volume":"69","author":"Berscheid","year":"2014","journal-title":"J Antimicrob Chemother"},{"key":"2022032112124092000_bib5","doi-asserted-by":"crossref","first-page":"56","DOI":"10.1016\/S1473-3099(18)30605-4","article-title":"Attributable deaths and disability-adjusted life-years caused by infections with antibiotic-resistant bacteria in the EU and the European Economic Area in 2015: a population-level modelling analysis","volume":"19","author":"Cassini","year":"2018","journal-title":"Lancet Infect Dis"},{"key":"2022032112124092000_bib1_588_1588143617744","article-title":"Antibiotic resistance threats in the united States","author":"Centers\u00a0for\u00a0Disease\u00a0Control\u00a0and\u00a0Prevention","year":"2013"},{"key":"2022032112124092000_bib6","doi-asserted-by":"crossref","first-page":"1342","DOI":"10.1056\/NEJMoa025025","article-title":"Infection with vancomycin-resistant Staphylococcus aureus containing the vanA resistance gene","volume":"348","author":"Chang","year":"2003","journal-title":"N Engl J Med"},{"key":"2022032112124092000_bib7","volume-title":"Methods for Dilution Antimicrobial Susceptibility Tests f or Bacteria That Grow Aerobically; Approved Standard - Ninth Edition","author":"CLSI","year":"2012"},{"key":"2022032112124092000_bib8","doi-asserted-by":"crossref","first-page":"1363","DOI":"10.1007\/s00284-011-9868-6","article-title":"Vancomycin-resistance transferability from VanA enterococci to Staphylococcus aureus","volume":"62","author":"de\u00a0Niederh\u00e4usern","year":"2011","journal-title":"Curr Microbiol"},{"key":"2022032112124092000_bib9","doi-asserted-by":"crossref","first-page":"327","DOI":"10.1086\/430909","article-title":"Comparison of mortality associated with vancomycin-resistant and vancomycin-susceptible enterococcal bloodstream infections: a meta-analysis","volume":"41","author":"DiazGranados","year":"2005","journal-title":"Clin Infect Dis"},{"key":"2022032112124092000_bib10","doi-asserted-by":"crossref","first-page":"134","DOI":"10.18683\/germs.2018.1140","article-title":"Vancomycin resistance among Staphylococcus aureus isolates in a rural setting, Egypt","volume":"8","author":"ElSayed","year":"2018","journal-title":"Germs"},{"key":"2022032112124092000_bib11","volume-title":"Surveillance of Antimicrobial Resistance in Europe \u2013 Annual Report of the European Antimicrobial Resistance Surveillance Network (EARS-Net) 2017","author":"European Centre for Disease Prevention and Control","year":"2018"},{"key":"2022032112124092000_bib12","doi-asserted-by":"crossref","first-page":"4","DOI":"10.1016\/j.jgar.2018.01.017","article-title":"Emergence of vancomycin intermediate and resistant Staphylococcus aureus among methicillin resistant S. aureus isolated from clinical specimens in the northwest of Iran","volume":"14","author":"Ghahremani","year":"2018","journal-title":"J Glob Antimicrob Resist"},{"key":"2022032112124092000_bib13","doi-asserted-by":"crossref","first-page":"S11","DOI":"10.1016\/S0924-8579(00)00300-9","article-title":"Acquired and intrinsic glycopeptide resistance in enterococci","volume":"16 Suppl 1","author":"Gholizadeh","year":"2000","journal-title":"Int J Antimicrob Agents"},{"key":"2022032112124092000_bib14","doi-asserted-by":"crossref","first-page":"158","DOI":"10.4103\/0976-500X.83279","article-title":"Antibiotic sensitivity profile of bacterial pathogens in postoperative wound infections at a tertiary care hospital in Gujarat, India","volume":"2","author":"Goswami","year":"2011","journal-title":"J Pharmacol Pharmacother"},{"key":"2022032112124092000_bib17","doi-asserted-by":"crossref","first-page":"200","DOI":"10.1007\/978-0-387-78885-2_14","article-title":"Vancomycin resistance VanS\/VanR two-component systems","volume":"631","author":"Hong","year":"2008","journal-title":"Adv Exp Med Biol"},{"key":"2022032112124092000_bib18","doi-asserted-by":"crossref","first-page":"1601","DOI":"10.3389\/fmicb.2016.01601","article-title":"Molecular events for promotion of vancomycin resistance in vancomycin intermediate Staphylococcus aureus","volume":"7","author":"Hu","year":"2016","journal-title":"Front Microbiol"},{"key":"2022032112124092000_bib15","doi-asserted-by":"crossref","first-page":"3752","DOI":"10.1128\/AAC.02096-12","article-title":"Compensation of the metabolic costs of antibiotic resistance by physiological adaptation in Escherichia coli","volume":"57","author":"H\u00e4ndel","year":"2013","journal-title":"Antimicrob Agents Chemother"},{"key":"2022032112124092000_bib19","doi-asserted-by":"crossref","first-page":"17092","DOI":"10.1038\/srep17092","article-title":"Phenotypic and genomic comparisons of highly vancomycin-resistant Staphylococcus aureus strains developed from multiple clinical MRSA strains by in vitro mutagenesis","volume":"5","author":"Ishii","year":"2015","journal-title":"Sci Rep"},{"key":"2022032112124092000_bib20","doi-asserted-by":"crossref","first-page":"1216","DOI":"10.1128\/jcm.26.6.1216-1218.1988","article-title":"Recovery of resistant enterococci during vancomycin prophylaxis","volume":"26","author":"Kaplan","year":"1988","journal-title":"J Clin Microbiol"},{"key":"2022032112124092000_bib21","article-title":"Enterococcal infection\u2014treatment and antibiotic resistance","volume-title":"Enterococci: From Commensals to Leading Causes of Drug Resistant Infection","author":"Kristich","year":"2014"},{"key":"2022032112124092000_bib22","doi-asserted-by":"crossref","first-page":"4025","DOI":"10.1128\/AAC.00200-09","article-title":"Evaluation of target specificity of antibacterial agents using Staphylococcus aureus ddlA mutants and D-cycloserine in a silkworm infection model","volume":"53","author":"Kurokawa","year":"2009","journal-title":"Antimicrob Agents Chemother"},{"key":"2022032112124092000_bib23","doi-asserted-by":"crossref","first-page":"978","DOI":"10.1128\/jb.110.3.978-987.1972","article-title":"Mechanism of D-cycloserine action: alanine racemase from Escherichia coli W","volume":"110","author":"Lambert","year":"1972","journal-title":"J Bacteriol"},{"key":"2022032112124092000_bib24","doi-asserted-by":"crossref","first-page":"157","DOI":"10.1056\/NEJM198807213190307","article-title":"Plasmid-mediated resistance to vancomycin and teicoplanin in Enterococcus faecium","volume":"319","author":"Leclercq","year":"1988","journal-title":"N Engl J Med"},{"key":"2022032112124092000_bib25","doi-asserted-by":"crossref","first-page":"415","DOI":"10.1016\/j.idc.2016.02.006","article-title":"Vancomycin-resistant enterococci: therapeutic challenges in the 21st century","volume":"30","author":"Miller","year":"2016","journal-title":"Infect Dis Clin North Am"},{"key":"2022032112124092000_bib26","doi-asserted-by":"crossref","first-page":"2469","DOI":"10.1128\/JB.00153-10","article-title":"High-quality draft genome sequences of 28 Enterococcus sp. isolates","volume":"192","author":"Palmer","year":"2010","journal-title":"J Bacteriol"},{"key":"2022032112124092000_bib2_455_1588143955727","doi-asserted-by":"crossref","first-page":"1233","DOI":"10.1021\/ml400349n","article-title":"Metabolomics Reveal D-Alanine:D-Alanine Ligase As the Target of D-Cycloserine in Mycobacterium tuberculosis","volume":"4","author":"Prosser","year":"2013","journal-title":"ACS Med Chem Lett"},{"key":"2022032112124092000_bib27","doi-asserted-by":"crossref","first-page":"943","DOI":"10.1007\/BF01967563","article-title":"Structure, biochemistry and mechanism of action of glycopeptide antibiotics","volume":"8","author":"Reynolds","year":"1989","journal-title":"Eur J Clin Microbiol Infect Dis"},{"key":"2022032112124092000_bib28","doi-asserted-by":"crossref","first-page":"1524","DOI":"10.1056\/NEJMoa1303359","article-title":"Transferable vancomycin resistance in a community-associated MRSA lineage","volume":"370","author":"Rossi","year":"2014","journal-title":"N Engl J Med"},{"key":"2022032112124092000_bib29","doi-asserted-by":"crossref","first-page":"1588","DOI":"10.1128\/AAC.33.9.1588","article-title":"In vitro susceptibility studies of vancomycin-resistant Enterococcus faecalis","volume":"33","author":"Sahm","year":"1989","journal-title":"Antimicrob Agents Chemother"},{"key":"2022032112124092000_bib30","doi-asserted-by":"crossref","DOI":"10.1093\/ijnp\/pyv102","article-title":"D-cycloserine in neuropsychiatric diseases: a systematic review","volume":"19","author":"Schade","year":"2016","journal-title":"Int J Neuropsychopharmacol"},{"key":"2022032112124092000_bib31","doi-asserted-by":"crossref","first-page":"693","DOI":"10.3181\/00379727-101-25064","article-title":"Reversal of cycloserine inhibition by D-alanine","volume":"101","author":"Shockman","year":"1959","journal-title":"Proceedings of the Society for Experimental Biology and Medicine"},{"key":"2022032112124092000_bib32","doi-asserted-by":"crossref","first-page":"1687","DOI":"10.1128\/JCM.41.4.1687-1693.2003","article-title":"Evolution of a vancomycin-intermediate Staphylococcus aureus strain in vivo: multiple changes in the antibiotic resistance phenotypes of a single lineage of methicillin-resistant S. aureus under the impact of antibiotics administered for chemotherapy","volume":"41","author":"Sieradzki","year":"2003","journal-title":"J Clin Microbiol"},{"key":"2022032112124092000_bib33","doi-asserted-by":"crossref","first-page":"e156","DOI":"10.1097\/ICO.0b013e31828ffe0e","article-title":"Combination effect of antibiotics against bacteria isolated from keratitis using fractional inhibitory concentration index","volume":"32","author":"Suzuki","year":"2013","journal-title":"Cornea"},{"key":"2022032112124092000_bib34","doi-asserted-by":"crossref","first-page":"907","DOI":"10.1038\/ja.2017.56","article-title":"D-cycloserine increases the effectiveness of vancomycin against vancomycin-highly resistant Staphylococcus aureus","volume":"70","author":"Tabuchi","year":"2017","journal-title":"J Antibiot"},{"key":"2022032112124092000_bib35","doi-asserted-by":"crossref","first-page":"807","DOI":"10.1128\/am.29.6.807-813.1975","article-title":"Improved medium for lactic streptococci and their bacteriophages","volume":"29","author":"Terzaghi","year":"1975","journal-title":"Appl Microbiol"},{"key":"2022032112124092000_bib16","doi-asserted-by":"crossref","first-page":"467","DOI":"10.1016\/j.tim.2017.01.004","article-title":"Multidrug-resistant enterococcal infections: new compounds, novel antimicrobial therapies?","volume":"25","author":"van\u00a0Harten","year":"2017","journal-title":"Trends Microbiol"},{"key":"2022032112124092000_bib36","doi-asserted-by":"crossref","first-page":"343","DOI":"10.1556\/030.64.2017.033","article-title":"Occurrence of vancomycin-resistant Staphylococcus aureus in the oral cavity of patients with dental caries","volume":"64","author":"Vellappally","year":"2017","journal-title":"Acta Microbiol Immunol Hung"},{"key":"2022032112124092000_bib37","doi-asserted-by":"crossref","DOI":"10.1128\/AAC.02253-16","article-title":"Antibiotic effects on methicillin-resistant Staphylococcus aureus cytoplasmic peptidoglycan intermediate levels and evidence for potential metabolite level regulatory loops","volume":"61","author":"Vemula","year":"2017","journal-title":"Antimicrob Agents Chemother"},{"key":"2022032112124092000_bib38","doi-asserted-by":"crossref","first-page":"1569","DOI":"10.1126\/science.1090956","article-title":"Genetic analysis of a high-level vancomycin-resistant isolate of Staphylococcus aureus","volume":"302","author":"Weigel","year":"2003","journal-title":"Science"}],"container-title":["FEMS Microbiology Letters"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/academic.oup.com\/femsle\/advance-article-pdf\/doi\/10.1093\/femsle\/fnaa062\/33034768\/fnaa062.pdf","content-type":"application\/pdf","content-version":"am","intended-application":"syndication"},{"URL":"https:\/\/academic.oup.com\/femsle\/article-pdf\/367\/8\/fnaa062\/42960905\/fnaa062.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"syndication"},{"URL":"https:\/\/academic.oup.com\/femsle\/article-pdf\/367\/8\/fnaa062\/42960905\/fnaa062.pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2022,3,21]],"date-time":"2022-03-21T12:17:07Z","timestamp":1647865027000},"score":1,"resource":{"primary":{"URL":"https:\/\/academic.oup.com\/femsle\/article\/doi\/10.1093\/femsle\/fnaa062\/5819017"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2020,4,1]]},"references-count":40,"journal-issue":{"issue":"8","published-print":{"date-parts":[[2020,4,1]]}},"URL":"https:\/\/doi.org\/10.1093\/femsle\/fnaa062","relation":{},"ISSN":["1574-6968"],"issn-type":[{"value":"1574-6968","type":"electronic"}],"subject":[],"published-other":{"date-parts":[[2020,4]]},"published":{"date-parts":[[2020,4,1]]},"article-number":"fnaa062"}}